Silver Trust Ishares (SLV) 13.92 $SLV Sell When You Can,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Silver Trust Ishares (SLV) 13.92 $SLV

Sell When You Can, Not When You Have To
at The Street - Fri Jul 24, 10:57AM CDT
If your stocks are doing well, it may be time to trim.
AMBA: 119.45 (-4.78), AMZN: 531.41 (+1.99), FB: 94.17 (-2.78), LLTC: 40.27 (+0.06), SNE: 28.88 (-0.39), GOOGL: 658.27 (+3.50), SLV: 13.92 (-0.10), SPLK: 70.60 (-3.31), GDX: 13.57 (-0.51), GOOG: 627.26 (+3.70)

Gold's Bottom in Sight as Commodities Hit Multi-Year Lows - 'Bubba' Horwitz
at The Street - Tue Jul 21, 2:59PM CDT
As commodities hit 13-year lows, one expert says gold may be near its bottom.
TST: 1.82 (unch), GLD: 104.86 (-0.49), SLV: 13.92 (-0.10), GCC: 20.08 (-0.28)

iShares Silver Trust (SLV) : Short Sell @ $14.15
Trading Central - Tue Jul 21, 1:57PM CDT
# TECHNICAL VIEW # (Daily Chart) *the iShares Silver Trust (SLV) is trading a steep declining channel *the break below the previous low at 14.60 has major bearish implications Regarding technical indicators: the 20-day moving average (in red) and...
SLV: 13.92 (-0.10)

After Yesterday's Decline of 1.26%, iShares Silver Trust Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jul 20, 5:21PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $14.03 to a high of $14.35. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $14.19 on volume of 9.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLV: 13.92 (-0.10)

iShares Silver Trust Falls 1.26% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Jul 20, 5:20PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $14.03 to a high of $14.35. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $14.19 on volume of 9.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLV: 13.92 (-0.10)

Major Player Dumping Gold? Gold Experts Weigh In on Sharp Selloff
at The Street - Mon Jul 20, 4:26PM CDT
With gold prices hitting a 5-year low overnight, experts weigh in to explain the sudden drop.
GD: 142.41 (-0.21), GLD: 104.86 (-0.49), SLV: 13.92 (-0.10)

SmarTrend Watching for Potential Rebound in Shares of iShares Silver Trust After 1.77% Loss
Comtex SmarTrend(R) - Wed Jul 15, 5:59PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $14.36 to a high of $14.47. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $14.63 on volume of 7.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLV: 13.92 (-0.10)

Gold and Silver: Dealing With Hated Metals
at The Street - Mon Jul 13, 2:00PM CDT
Fear is widespread, but should you totally avoid?
SLV: 13.92 (-0.10)

Manipulation Researcher Finds 'Very Sharp Movements' in Silver Prices
at The Street - Thu Jul 09, 5:30PM CDT
Rosa Abrantes-Metz once suggested there was collusive behavior in the gold market. Now the economist and professor is shifting her focus to silver.
CME: 95.55 (-1.11), GLD: 104.86 (-0.49), HSBC: 43.89 (-0.18), DB: 32.71 (-0.51), SLV: 13.92 (-0.10), TRI: 37.29 (-0.27), BNS: 46.86 (-0.93)

U.S. Dollar Is Now the Safe Haven Asset, Not Gold
at The Street - Wed Jul 08, 5:59PM CDT
Gold has been trading in range around $1,200 this year.
GLD: 104.86 (-0.49), SLV: 13.92 (-0.10), GDX: 13.57 (-0.51), UUP: 25.25 (-0.20), JJC: 27.59 (-0.54)

Gold Still Shines and Is One of the Best Performers
at The Street - Wed Jul 08, 5:54PM CDT
After hitting a 3-1/2 month low overnight, gold ended the U.S. day session moderately higher.
GLD: 104.86 (-0.49), SLV: 13.92 (-0.10)

iShares Silver Trust Set to Possibly Rebound After Yesterday's Selloff of 3.74%
Comtex SmarTrend(R) - Tue Jul 07, 5:06PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $14.03 to a high of $14.58. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $14.86 on volume of 24.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLV: 13.92 (-0.10)

Look for Shares of iShares Silver Trust to Potentially Rebound after Yesterday's 3.74% Sell Off
Comtex SmarTrend(R) - Tue Jul 07, 5:05PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $14.03 to a high of $14.58. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $14.86 on volume of 24.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLV: 13.92 (-0.10)

Uncertainty Escalates After Greek Referendum
David Fry - at Seeking Alpha - Mon Jul 06, 11:14PM CDT
At this point words fail me once again. What will happen to Greece and their EU partners, no one knows. For now it's a cancer growing on both Greece and many world stock indexes. China is more alarming after the PBOC intervened in markets to no...
XLB: 44.58 (-0.50), GREK: 9.33 (-0.42), IBB: 373.58 (-4.00), EWO: 16.15 (-0.15), TLT: 122.04 (+0.65), EEM: 36.36 (-0.70), XLP: 49.65 (-0.03), SPY: 206.79 (-1.21), ITB: 27.09 (-0.08), IYR: 74.11 (+0.16), XLI: 52.64 (-0.26), SLV: 13.92 (-0.10), FXE: 108.90 (+1.15), XLF: 24.94 (-0.18), GDX: 13.57 (-0.51), JJC: 27.59 (-0.54), XLE: 68.51 (-1.00), FXI: 40.13 (-1.61), USO: 15.65 (-0.38), DBC: 15.83 (-0.31), DBA: 21.33 (-0.37), XLY: 78.26 (-0.59), FXY: 78.76 (+0.35), EZU: 38.10 (-0.35), XLU: 42.87 (+0.54), HAO: 26.11 (-1.99), UUP: 25.25 (-0.20), XRT: 96.33 (-0.81), XLV: 74.78 (-0.07), IEV: 43.83 (-0.35), GLD: 104.86 (-0.49), EPI: 21.52 (-0.41), RSX: 16.52 (-0.43), EFA: 63.42 (-0.47), EWZ: 28.05 (-0.45)

Why The Greek Gods Show Gold No Favor
Markos Kaminis - at Seeking Alpha - Mon Jul 06, 1:35PM CDT

VGK: 54.23 (-0.42), SPY: 206.79 (-1.21), GDXJ: 18.81 (-0.68), VXX: 17.72 (+0.88), GREK: 9.33 (-0.42), GOLD: 57.59 (-2.86), GLD: 104.86 (-0.49), OIL: 9.22 (-0.26), SLV: 13.92 (-0.10), NUGT: 3.33 (-0.41), GDX: 13.57 (-0.51)

Precious Metals: Second Quarter Review And The Outlook For Q3
Andrew Hecht - at Seeking Alpha - Mon Jul 06, 6:15AM CDT

GLDI: 10.73 (-0.02), PALL: 59.32 (-1.10), OUNZ: 10.90 (-0.05), UGLD: 8.40 (-0.11), SIVR: 14.31 (-0.11), DSLV: 72.94 (+1.86), GYEN: 12.29 (-0.12), SGOL: 106.95 (-0.46), GEUR: 12.23 (-0.23), AGQ: 31.18 (-0.50), GDXJ: 18.81 (-0.68), PTM: 10.63 (+0.03), SLV: 13.92 (-0.10), GDX: 13.57 (-0.51), ZSL: 125.63 (+2.24), PGM: 20.62 (unch), UGL: 32.22 (-0.29), GTU: 37.97 (-0.27), TBAR: 23.79 (+0.01), SLY: 104.91 (-0.87), PSLV: 5.59 (-0.09), USV: 19.35 (+0.37), DZZ: 8.50 (+0.07), DGL: 35.90 (-0.20), PPLT: 95.24 (-0.11), DGP: 19.57 (-0.21), DGLD: 91.33 (+1.56), DBS: 23.23 (+0.20), UBG: 28.27 (+0.01), USLV: 12.76 (-0.33), SLVO: 10.04 (-0.06), DGZ: 16.70 (+0.07), GLD: 104.86 (-0.49), PHYS: 9.00 (-0.04), IAU: 10.58 (-0.04), AGOL: 107.80 (+1.20), GLL: 112.92 (+1.05)

Is The Fed Making A Bad Bet Right Now With Zero Rates?
Michael Roat - at Seeking Alpha - Sun Jul 05, 12:57AM CDT

GLD: 104.86 (-0.49), SLV: 13.92 (-0.10), TLT: 122.04 (+0.65)

Greek Default Sparks Volatility, Contagion Fears (Podcast)
Money Metals Exchange - Seeking Alpha - Fri Jul 03, 11:17AM CDT
Analyst David Smith Speaks on Freedom, Personal Responsibility, and Prudent Investing Welcome to this week's Market Wrap Podcast , I'm Mike Gleason. Coming up we'll hear a tremendous and fascinating interview with David Smith of The Morgan...
1 Comment
PALL: 59.32 (-1.10), GTU: 37.97 (-0.27), OUNZ: 10.90 (-0.05), PSLV: 5.59 (-0.09), GREK: 9.33 (-0.42), SIVR: 14.31 (-0.11), PPLT: 95.24 (-0.11), SGOL: 106.95 (-0.46), GLD: 104.86 (-0.49), PHYS: 9.00 (-0.04), IAU: 10.58 (-0.04), SLV: 13.92 (-0.10), AGOL: 107.80 (+1.20)

Why 3 Terrorism Events Were A Non-Starter For Gold
Markos Kaminis - at Seeking Alpha - Tue Jun 30, 1:19PM CDT

GDXJ: 18.81 (-0.68), GLD: 104.86 (-0.49), DUST: 36.06 (+3.45), SLV: 13.92 (-0.10), NUGT: 3.33 (-0.41), GDX: 13.57 (-0.51), UUP: 25.25 (-0.20), GG: 12.61 (-0.67)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading